Promoters, threonine-producing recombinant microorganisms and their applications

By using a mutated dapA gene promoter in Corynebacterium glutamicum to regulate the expression of lysine and isoleucine synthesis genes, combined with enhanced aspartate kinase and homoserine dehydrogenase activities, the problem of insufficient carbon metabolic flux optimization was solved, and the yield and conversion rate of threonine were improved.

CN116536310BActive Publication Date: 2026-11-17MEIHUA BIOTECH LANGFANG CO LTD
View PDF 3 Cites 0 Cited by

Patent Information

Application Number
CN202210094640.8
Authority / Receiving Office
CN · China
Patent Type
Patents(China)
Current Assignee / Owner
Filing Date
2022-01-26
Publication Date
2026-11-17
Estimated Expiration
2042-01-26

AI Technical Summary

Technical Problem

Existing technologies have insufficient optimization of carbon metabolic flux for threonine production in Corynebacterium glutamicum, and direct knockout of the lysine synthesis gene leads to a decrease in strain growth rate, affecting threonine fermentation production.

Method used

By using a mutated dapA gene promoter to weaken the expression of lysine and isoleucine synthesis genes, combined with enhanced activity of aspartate kinase and homoserine dehydrogenase, the metabolic pathway is regulated through rationally designed promoters, thereby increasing the allocation of carbon metabolism to the threonine synthesis pathway.

Benefits of technology

It significantly improved the yield and conversion rate of threonine, reduced the accumulation of by-products, maintained the normal growth performance of the strain, and enhanced the threonine production capacity.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure BDA0003490555290000121
    Figure BDA0003490555290000121
  • Figure BDA0003490555290000131
    Figure BDA0003490555290000131
  • Figure BDA0003490555290000161
    Figure BDA0003490555290000161
Patent Text Reader

Abstract

This invention relates to the field of microbial engineering technology, specifically to promoters, threonine-producing recombinant microorganisms, and their applications. This invention provides a promoter having the nucleotide sequence shown in SEQ ID NO.1. Through rational design of the dapA gene promoter, this invention obtains a mutant dapA gene promoter with significantly reduced transcriptional activity, which can be used for attenuated expression of microbial genes. Replacing the original promoters of the dapA, ddh, ilvA, tdcB, and gltA genes in *Corynebacterium glutamicum* with this promoter significantly reduces the expression levels of these genes. In the recombinant microorganism constructed thereby, carbon metabolism flows more towards the threonine synthesis pathway, significantly improving the strain's ability to produce threonine. The threonine yield is significantly higher than that of the starting strain, while also exhibiting better growth performance.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] This invention relates to the field of microbial engineering technology, specifically to promoters, threonine-producing recombinant microorganisms, and their applications. Background Technology

[0002] L-Threonine, chemically known as β-hydroxy-α-aminobutyric acid, has the molecular formula C4H9NO3 and a relative molecular mass of 119.12. It is an essential amino acid, primarily used in pharmaceuticals, chemical reagents, food fortifiers, and feed additives.

[0003] In Corynebacterium glutamicum, the production of threonine from oxaloacetate requires five catalytic steps. The catalytic enzymes involved in these five steps are aspartate kinase (encoded by lysC), aspartate semialdehyde dehydrogenase (encoded by asd), homoserine dehydrogenase (encoded by hom), homoserine kinase (encoded by thrB), and threonine synthase (encoded by thrC). Regarding the lysC gene and the hom gene, there are reports on feedback-resistant hom genes and lysC genes (Reinscheid DJ, Eikmanns BJ, Sahm H. Analysis of a Corynebacterium glutamicum hom gene coding for afeedback-resistant homoserine dehydrogenase.[J]. Journal of Bacteriology, 1991, 173(10):3228-3230; Eikmanns BJ, Eggeling L, Sahm H. Molecular aspects of lysine, threonine, and isoleucine biosynthesis in Corynebacterium glutamicum.[J]. Antonie Van Leeuwenhoek, 1993, 64(2):145-163.). There are currently some reports on the construction of engineered bacteria that produce threonine by fermentation using Corynebacterium glutamicum. For example, Lothar Eggling et al. increased the threonine production from 49 mM to 67 mM by weakening the glyA gene encoding the threonine utilization pathway and overexpressing the threonine export protein ThrE (Simic P,Willuhn J,Sahm H, et al. Identification of glyA (Encoding SerineHydroxymethyltransferase) and Its Use Together with the Exporter ThrE To Increase L-Threonine Accumulation by Corynebacterium glutamicum[J]. Applied and Environmental Microbiology, 2002, 68(7):3321-3327.).

[0004] Current reports on the production of threonine using Corynebacterium glutamicum mainly focus on the metabolic engineering of the threonine synthesis pathway, while reports on the optimization of carbon metabolic flux are relatively few. Furthermore, in gene expression regulation within Corynebacterium glutamicum, gene enhancement primarily employs artificially synthesized strong promoters, strong promoters of endogenous genes, or the introduction of heterologous strong promoters; however, reports on promoters for gene attenuation are relatively scarce, and gene attenuation mainly relies on start codon substitution and gene knockout techniques. Summary of the Invention

[0005] The purpose of this invention is to provide a mutated dapA gene promoter. Another purpose of this invention is to provide recombinant microorganisms constructed using this promoter for gene expression regulation and their applications.

[0006] Specifically, the present invention provides the following technical solutions:

[0007] The present invention provides a promoter having a nucleotide sequence as shown in SEQ ID NO.1.

[0008] The promoter described above is the mutant dapA gene (4-hydroxy-tetrahydropyridine dicarboxylic acid synthase gene) promoter (mPdapA). This mutant promoter has the activity of initiating gene transcription, but compared with the wild-type dapA gene promoter, the activity of this promoter in initiating gene transcription is significantly reduced.

[0009] Preferably, the nucleotide sequence of the mutated dapA gene promoter is shown in SEQ ID NO.1.

[0010] The present invention also provides a biological material containing the above-mentioned mutated dapA gene promoter; the biological material is recombinant DNA, a vector, or a host cell.

[0011] The recombinant DNA described above may be recombinant DNA obtained by operably linking the target gene downstream of the promoter, or recombinant DNA obtained by operably linking the target gene downstream of the promoter and other transcriptional regulatory elements or translational regulatory elements upstream or downstream, or recombinant DNA obtained by operably linking a homologous arm fragment for homologous recombination upstream and / or downstream of the promoter.

[0012] The vectors mentioned above can be plasmid vectors, viral vectors, or transposons.

[0013] The host cell mentioned above is preferably a microbial cell.

[0014] The microbial cells are preferably Escherichia coli or Corynebacterium. Specifically, the Escherichia coli strain is preferably *Escherichia coli*; the Corynebacterium strain is preferably *Corynebacterium glutamicum*, *Corynebacterium pekinense*, *Corynebacterium efficiens*, *Corynebacterium crenatum*, *Corynebacterium thermoaminogenes*, or *Corynebacterium aminogenes*.

[0015] This invention provides the application of the above-mentioned mutated dapA gene promoter in initiating the expression of a target gene.

[0016] The specific application is as follows: the target gene is operatively linked to the mutated dapA gene promoter to obtain recombinant DNA, and the recombinant DNA is introduced into the host cell to express the target gene.

[0017] The aforementioned mutated dapA gene promoter can be used to drive the expression of metabolism-related genes of the target metabolite, especially to reduce the expression of competing pathway-related genes of the target metabolite, thereby increasing the accumulation of the target metabolite.

[0018] The present invention also provides the application of the above-mentioned mutated dapA gene promoter in increasing the yield or conversion rate of microbial metabolites, or in constructing production strains of microbial metabolites.

[0019] Preferably, the metabolite is threonine or a derivative thereof.

[0020] In the fermentation production of threonine, lysine and isoleucine are the main byproducts, and their synthesis pathways are the main competing pathways for threonine synthesis. Therefore, it is necessary to block or weaken byproduct pathways such as lysine synthesis to divert more carbon metabolic flux to the threonine synthesis pathway. However, directly knocking out genes such as dapA (the lysine synthesis gene) leads to a sharp decrease in strain growth rate or causes cellular nutrient deficiencies, which is detrimental to threonine fermentation production. This invention discovers that by using the mutated dapA gene promoter to weaken the lysine and isoleucine synthesis genes, nutrient deficiencies can be avoided. While ensuring normal strain growth, the allocation of carbon metabolic flux to the threonine synthesis pathway is significantly increased, enhancing the strain's threonine synthesis capacity and reducing the accumulation of lysine and isoleucine.

[0021] Based on the above findings, the present invention provides a recombinant microorganism in which the encoding gene of at least one enzyme selected from (1) to (4) is transcribed by the above-mentioned mutated dapA gene promoter:

[0022] (1) 4-Hydroxy-tetrahydropyridinedicarboxylic acid synthase;

[0023] (2) Diaminopimelic acid dehydrogenase;

[0024] (3) Threonine dehydratase;

[0025] (4) Citrate synthase.

[0026] In one embodiment of the present invention, in the recombinant microorganism, the encoding genes of 4-hydroxy-tetrahydropyridine dicarboxylic acid synthase and diaminopimelic acid dehydrogenase are transcribed by the above-mentioned mutated dapA gene promoter.

[0027] In another embodiment of the present invention, in the recombinant microorganism, the encoding genes of 4-hydroxy-tetrahydropyridine dicarboxylic acid synthase, diaminopimelic acid dehydrogenase, and threonine dehydratase are transcribed by the above-mentioned mutated dapA gene promoter.

[0028] In another embodiment of the present invention, in the recombinant microorganism, the encoding genes of 4-hydroxy-tetrahydropyridine dicarboxylic acid synthase, diaminopimelic acid dehydrogenase, threonine dehydratase, and citrate synthase are all transcribed by the above-mentioned mutated dapA gene promoter.

[0029] The reference sequence numbers of the above-mentioned 4-hydroxy-tetrahydropyridine dicarboxylic acid synthase, diaminopimelic acid dehydrogenase, threonine dehydratase, and citrate synthase on NCBI are WP_011014792.1, WP_011015254.1, WP_011014022.1, and WP_003862033.1, respectively, or amino acid sequences that have 90% similarity to the above reference sequences and have equivalent functions.

[0030] The transcription driven by the mutated dapA gene promoter described above specifically involves replacing the original promoter of the gene with the mutated dapA gene promoter.

[0031] The expression levels of 4-hydroxy-tetrahydropyridine dicarboxylic acid synthase, diaminopimelic acid dehydrogenase, threonine dehydratase, and citrate synthase in the recombinant microorganisms described above were significantly reduced, and their ability to synthesize threonine and its derivatives was significantly enhanced. They had significantly higher threonine yield and conversion rate than the starting strain, and the accumulation of by-products was significantly reduced.

[0032] Due to the strict metabolic regulation of microorganisms, the aspartate kinase and homoserine dehydrogenase in their threonine synthesis pathway are strictly regulated by the intracellular threonine concentration. Therefore, the starting strain capable of accumulating threonine must first unlock its synthesis pathway, mainly by relieving feedback inhibition of aspartate kinase and homoserine dehydrogenase, and enhancing enzyme activity.

[0033] Specifically, in the recombinant microorganism, the enzyme activities of aspartate kinase and / or homoserine dehydrogenase are enhanced and / or feedback inhibition is relieved.

[0034] The reference sequence numbers for aspartate kinase and homoserine dehydrogenase on NCBI are WP_003855724.1 and WP_003854900.1, respectively, or amino acid sequences that are 90% similar to the above reference sequences and have the same function.

[0035] Preferably, the microorganism is any one of the following ① to ⑦:

[0036] ① Microorganisms whose encoding gene for 4-hydroxy-tetrahydropyridine dicarboxylic acid synthase is transcribed by the above-mentioned mutated dapA gene promoter, and whose enzyme activities of aspartate kinase and / or homoserine dehydrogenase are enhanced and / or whose feedback inhibition is relieved.

[0037] ② Microorganisms whose encoding gene for diaminopimelic acid dehydrogenase is transcribed by the above-mentioned mutated dapA gene promoter, and whose enzyme activities of aspartate kinase and / or homoserine dehydrogenase are enhanced and / or whose feedback inhibition is relieved.

[0038] ③ Microorganisms whose encoding gene for threonine dehydratase is transcribed by the above-mentioned mutated dapA gene promoter, and whose enzyme activities of aspartate kinase and / or homoserine dehydrogenase are enhanced and / or whose feedback inhibition is relieved.

[0039] ④ Microorganisms whose coding gene for citrate synthase is transcribed by the above-mentioned mutated dapA gene promoter, and whose enzyme activities of aspartate kinase and / or homoserine dehydrogenase are enhanced and / or whose feedback inhibition is relieved.

[0040] ⑤ Microorganisms whose encoding genes for 4-hydroxy-tetrahydropyridine dicarboxylic acid synthase and diaminopimelic acid dehydrogenase are transcribed by the above-mentioned mutated dapA gene promoter, and whose enzyme activities of aspartate kinase and / or homoserine dehydrogenase are enhanced and / or whose feedback inhibition is relieved.

[0041] ⑥ Microorganisms whose encoding genes for 4-hydroxy-tetrahydropyridine dicarboxylic acid synthase, diaminopimelic acid dehydrogenase, and threonine dehydratase are transcribed by the above-mentioned mutated dapA gene promoter, and whose enzyme activities of aspartate kinase and / or homoserine dehydrogenase are enhanced and / or whose feedback inhibition is relieved.

[0042] ⑦ Microorganisms whose encoding genes for 4-hydroxy-tetrahydropyridine dicarboxylic acid synthase, diaminopimelic acid dehydrogenase, threonine dehydratase, and citrate synthase are transcribed by the above-mentioned mutated dapA gene promoter, and whose enzyme activities of aspartate kinase and / or homoserine dehydrogenase are enhanced and / or whose feedback inhibition is relieved.

[0043] Preferably, the enhancement of enzyme activity is achieved by selecting from 1) to 6), or an optional combination thereof:

[0044] 1) Enhancement is achieved by introducing a plasmid containing the gene encoding the enzyme;

[0045] 2) Enhanced by increasing the copy number of the gene encoding the enzyme on the chromosome;

[0046] 3) Enhancement is achieved by altering the promoter sequence of the gene encoding the enzyme on the chromosome;

[0047] 4) Enhancement is achieved by operatively linking a strong promoter to the gene encoding the enzyme;

[0048] 5) Enhancement is achieved by altering the amino acid sequence of the enzyme;

[0049] 6) Enhancement is achieved by altering the nucleotide sequence encoding the enzyme.

[0050] For Corynebacterium glutamicum, the threonine dehydratase is encoded by the ilvA and tdcB genes.

[0051] More preferably, the enhanced enzyme activity is achieved by replacing the original promoter of the enzyme's encoding gene with a strong promoter.

[0052] The strong promoter is preferably Psod or PcspB.

[0053] The enhanced enzyme activity of aspartate kinase is preferably achieved by replacing the original promoter of its encoding gene with the strong Psod promoter and mutating its start codon to ATG.

[0054] Enhancing the enzyme activity of homoserine dehydrogenase is preferably achieved by replacing the original promoter of the encoding gene with a strong PcspB promoter.

[0055] The desensitization of feedback inhibition of aspartate kinase is preferably achieved by inducing a T311I mutation in it.

[0056] The preferred method to relieve feedback inhibition of homoserine dehydrogenase is to induce a G378E mutation in it.

[0057] The recombinant microorganisms described in this invention are preferably Corynebacterium bacteria; more preferably, Corynebacterium glutamicum. Corynebacterium glutamicum includes ATCC13032, ATCC13870, ATCC13869, ATCC21799, ATCC21831, ATCC14067, ATCC13287, etc. (see NCBI Corunebacterium glutamicum phylogenetic tree https: / / www.ncbi.nlm.nih.gov / genome / 469), and more preferably Corynebacterium glutamicum ATCC 13032.

[0058] The present invention also provides a method for constructing the above-mentioned recombinant microorganism, the method comprising replacing the promoter of the encoding gene of at least one of 4-hydroxy-tetrahydropyridine dicarboxylic acid synthase, diaminopimelic acid dehydrogenase, threonine dehydratase and citrate synthase with the above-mentioned mutated dapA gene promoter.

[0059] Preferably, the method further includes: enhancing the enzyme activity of aspartate kinase and / or homoserine dehydrogenase and / or relieving their feedback inhibition;

[0060] The enhancement of enzyme activity is achieved by selecting from 1) to 6) below, or an optional combination thereof:

[0061] 1) Enhancement is achieved by introducing a plasmid containing the gene encoding the enzyme;

[0062] 2) Enhanced by increasing the copy number of the gene encoding the enzyme on the chromosome;

[0063] 3) Enhancement is achieved by altering the promoter sequence of the gene encoding the enzyme on the chromosome;

[0064] 4) Enhancement is achieved by operatively linking a strong promoter to the gene encoding the enzyme;

[0065] 5) Enhancement is achieved by altering the amino acid sequence of the enzyme;

[0066] 6) Enhancement is achieved by altering the nucleotide sequence encoding the enzyme.

[0067] The aforementioned methods for modifying the strains, including gene enhancement, are all modifications known to those skilled in the art. See Man Zaiwei, Systematic Pathway Engineering of High-Yielding L-Arginine Corynebacterium [D]. Jiangnan University, 2016; Cui Yi, Metabolic Engineering of Corynebacterium Glutamate for L-Leucine Production [D]. Tianjin University of Science and Technology; Xu Guodong, Construction and Fermentation Condition Optimization of L-Isoleucine-Producing Strains. Tianjin University of Science and Technology, 2015.

[0068] This invention also provides any of the following applications of the recombinant microorganism:

[0069] (1) Application in the fermentation production of microbial metabolites or their derivatives;

[0070] (2) Application in the selection of production strains of microbial metabolites or their derivatives;

[0071] (3) Application in increasing the yield and / or conversion rate of microbial metabolites.

[0072] Preferably, the microbial metabolite is threonine.

[0073] The present invention also provides a method for producing threonine or its derivatives by fermentation, the method comprising the steps of culturing the recombinant microorganism and isolating threonine or its derivatives from the culture.

[0074] Specifically, the above method includes: inoculating the recombinant microorganism into a seed culture medium for seed culture to obtain a seed liquid; inoculating the seed liquid into a fermentation culture medium for culture to obtain a fermentation broth; and separating and extracting the fermentation broth to obtain threonine or its derivatives.

[0075] Preferably, the fermentation medium comprises the following components: corn steep liquor 45-55 mL / L, glucose 25-35 g / L, ammonium sulfate 3-5 g / L, MOPS 25-35 g / L, potassium dihydrogen phosphate 8-12 g / L, urea 15-25 g / L, biotin 8-12 mg / L, magnesium sulfate 5-7 g / L, ferrous sulfate 0.5-1.5 g / L, and vitamin C. B1 • HCl 35-45 mg / L, calcium pantothenate 45-55 mg / L, nicotinamide 35-45 mg / L, manganese sulfate 0.5-1.5 g / L, zinc sulfate 15-25 mg / L, copper sulfate 15-25 mg / L, pH 7.0-7.2.

[0076] The beneficial effects of this invention are as follows: By rationally designing the promoter of the dapA gene, this invention obtains a mutant dapA gene promoter with significantly reduced transcriptional activity, which can be used for attenuated expression of microbial genes.

[0077] By replacing the original promoters encoding 4-hydroxy-tetrahydropyridine dicarboxylic acid synthase, diaminopimelic acid dehydrogenase, threonine dehydratase, and citrate synthase in Corynebacterium glutamicum with this promoter, the expression levels of these genes were significantly reduced. As a result, the carbon metabolic flux in the recombinant microorganism constructed was directed more towards the threonine synthesis pathway, and the strain's ability to produce threonine was significantly improved. The threonine yield was increased by 279% compared to the original strain, while also exhibiting good growth performance. Detailed Implementation

[0078] The following examples are used to illustrate the present invention, but are not intended to limit the scope of the invention.

[0079] The following examples involve detailed information about the genes and enzymes:

[0080] Aspartate kinase, encoding gene name lysC, NCBI number: cg0306, Cgl0251, NCgl0247.

[0081] Homoserine dehydrogenase, encoded by gene name hom, NCBI ID: cg1337, Cgl1183, NCgl1136.

[0082] 4-Hydroxy-tetrahydropyridine dicarboxylic acid synthase, encoded by gene dapA, NCBI ID: cg2161, Cgl1971, NCgl1896.

[0083] Diaminopimelic acid dehydrogenase, encoded by gene ddh, NCBI ID: cg2900, Cgl2617, NCgl2528.

[0084] Threonine dehydratase, encoded by gene ilvA, NCBI ID: cg2334, Cgl2127, NCgl2046.

[0085] Threonine dehydratase, encoded by gene tdcB, NCBI ID: cg1116, Cgl0978, NCgl0939.

[0086] Citrate synthase, encoded by gene gltA, NCBI ID: cg0949, Cgl0829, NCgl0795.

[0087] This invention constructs a threonine-producing strain by metabolic engineering based on the wild-type Corynebacterium glutamicum strain ATCC13032. First, the threonine synthesis pathway is opened, mainly involving the removal of feedback inhibition and enhancement of aspartate kinase (lysC) and homoserine dehydrogenase (hom). Specifically, the expression of aspartate kinase is enhanced in Corynebacterium glutamicum ATCC13032, and the feedback inhibition of this enzyme is removed through mutation, resulting in the modified strain SMCT136. Furthermore, the expression of homoserine dehydrogenase is enhanced, and the feedback inhibition of this enzyme is removed through mutation, resulting in the modified strain SMCT137. This strain possesses preliminary threonine synthesis capabilities, with a threonine yield of 2.4 g / L.

[0088] For the modified strain SMCT137, lysine and isoleucine are the main byproducts of threonine fermentation, and the lysine and isoleucine synthesis pathways are the main competing pathways for threonine synthesis. Therefore, it is necessary to block or weaken byproduct pathways such as lysine synthesis to divert more carbon metabolic flux to the threonine synthesis pathway. However, directly knocking out lysine synthesis genes such as dapA leads to a sharp decrease in strain growth rate or causes cellular nutrient deficiencies, which is detrimental to threonine fermentation. Therefore, this invention employs a rational modification method of the dapA gene promoter, rationally designing and screening to obtain a mutant dapA gene promoter (mPdapA) to reduce the expression level of 4-hydroxy-tetrahydropyridine dicarboxylic acid synthase, thereby achieving the goal of balancing cell growth and optimizing carbon flux. Based on SMCT137, this invention performed a site-directed mutagenesis on the promoter of the dapA gene encoding 4-hydroxy-tetrahydropyridine dicarboxylic acid synthase in the lysine synthesis pathway (replacing the original dapA gene promoter with the mutated dapA promoter) to obtain strain SMCT138. In this strain, the expression level of 4-hydroxy-tetrahydropyridine dicarboxylic acid synthase decreased, the ability to produce threonine increased from 2.4 g / L to 3.0 g / L, and the content of the byproduct lysine decreased from 1.1 g / L to 0.8 g / L.

[0089] Furthermore, this invention uses SMCT137 as the starting strain and replaces the promoters of ddh, ilvA, tdcB, and gltA with the mutant dapA promoter to obtain modified strains SMCT139, SMCT140, SMCT141, and SMCT142. Verification showed that the expression levels of the corresponding protein diaminopimelic acid dehydrogenase, threonine dehydratase (ilvA), threonine dehydratase (tdcB), and citrate synthase decreased. Replacement of the ddh promoter reduced lysine content from 1.1 g / L to 0.9 g / L and increased threonine production by 0.4 g / L. Replacement of the ilvA and tdcB promoters reduced isoleucine content by 0.6 g / L and 0.2 g / L, respectively, and increased threonine production by 0.8 g / L and 0.6 g / L, respectively. Replacement of the gltA promoter increased threonine production by 0.8 g / L.

[0090] Furthermore, based on the aforementioned individual weakening, the modifications at the above sites were gradually integrated into SMCT138 to obtain modified strains SMCT143, SMCT144, SMCT145, and SMCT146. Modified strain SMCT143 showed a 20% increase in threonine production and a decrease in the byproduct lysine from 0.8 g / L to 0.4 g / L; modified strain SMCT144 showed a 67% increase in threonine production and a decrease in the byproduct isoleucine from 1.3 g / L to 0.6 g / L; modified strain SMCT145 showed a 113% increase in threonine production and a decrease in the byproduct isoleucine from 0.6 g / L to 0.3 g / L; and modified strain SMCT146 showed a 203% increase in threonine production.

[0091] The following examples illustrate the construction process of the modified bacteria and the performance of the strain in producing threonine through fermentation.

[0092] Example 1: Construction of plasmids for strain genome modification

[0093] 1. Aspartate kinase expression enhancement plasmid pK18mobsacB-Psod-lysC g1a-T311I Construction

[0094] Using the ATCC13032 genome as a template, PCR amplification with primers P21 / P22 yielded the upstream homologous arm up; PCR amplification with primers P23 / P24 yielded the promoter fragment Psod; and PCR amplification with primers P25 / P26 yielded lysC. g1a-T311I PCR amplification was performed using primers P27 / P28 to obtain the downstream homologous arm dn. Fusion PCR was then performed using primers P21 / P24 with up and Psod as templates to obtain the up-Psod fragment. Finally, PCR amplification was performed using primers P21 / P28 with up-Psod and lysC... g1a-T311I Using dn as a template, fusion PCR was performed to obtain the full-length fragment up-Psod-lysC. g1a-T311I -dn. pK18mobsacB was digested with BamHI / HindIII. Both were assembled using a seamless cloning kit and transformed into Trans1 T1 competent cells to obtain the recombinant plasmid pK18mobsacB-Psod-lysC. g1a-T311I .

[0095] 2. Homoserine dehydrogenase expression enhancement plasmid pK18mobsacB-PcspB-hom G378E Construction

[0096] The plasmid construction method is as described in 1. The primers used are P29, P30, P31, P32, P33, P34, P35, and P36.

[0097] 3. Construction of the 4-hydroxy-tetrahydropyridine dicarboxylic acid synthase promoter replacement plasmid pK18mobsacB-ΔPdapA::mPdapA

[0098] A synthetically produced mutant dapA promoter, mPdapA (sequence shown in SEQ ID NO.1), was used. Using the synthetic mPdapA sequence as a template, PCR amplification was performed with primers PW21 / 22 to obtain the mPdapA promoter fragment. Using the ATCC13032 genome as a template, PCR amplification was performed with primers PW1 / 2 to obtain the upstream homologous arm up, and with primers PW3 / 4 to obtain the upstream homologous arm dn. Fusion PCR was performed using primers PW1 / 4 with up, mPdapA, and dn as templates to obtain the fragment up-mPdapA-dn. pK18mobsacB was digested with BamHI / HindIII. Both were assembled using a seamless cloning kit and transformed into Trans1 T1 competent cells to obtain the recombinant plasmid pK18mobsacB-ΔPdapA::mPdapA.

[0099] 4. Construction of the diaminopimelic acid dehydrogenase promoter replacement plasmid pK18mobsacB-ΔPddh::mPdapA

[0100] The plasmid construction method is described in section 3. The primers used are PW5, PW6, PW7, PW8, PW21, and PW22.

[0101] 5. Construction of the threonine dehydratase (ilvA) promoter replacement plasmid pK18mobsacB-ΔPilvA::mPdapA

[0102] The plasmid construction method is described in section 3. The primers used are PW9, PW10, PW11, PW12, PW21, and PW22.

[0103] 6. Construction of the threonine dehydratase (tdcB) promoter replacement plasmid pK18mobsacB-ΔPtdcB::mPdapA

[0104] The plasmid construction method is described in section 3. The primers used are PW13, PW14, PW15, PW16, PW21, and PW22.

[0105] 7. Construction of citrate synthase promoter replacement plasmid pK18mobsacB-ΔPgltA::mPdapA

[0106] The plasmid construction method is described in section 3. The primers used are PW17, PW18, PW19, PW20, PW21, and PW22.

[0107] The primers used in the construction of the above plasmids are shown in Table 1.

[0108] Table 1 Primer sequences

[0109]

[0110]

[0111] Example 2 Construction of Genome-Modified Strains

[0112] 1. Construction of strains with enhanced expression of aspartate kinase

[0113] ATCC13032 competent cells were prepared according to the classic method for *Corynebacterium glutamicum* (C. glutamicum Handbook, Charter 23). The recombinant plasmid pK18mobsacB-Psod-lysC was used. g1a-T311I Competent cells were transformed by electroporation, and transformants were screened on selective medium containing 15 mg / L kanamycin, where the target gene was inserted into the chromosome due to homology. The selected transformants were cultured overnight in standard liquid brain heart extract medium at 30°C with shaking at 220 rpm. During this culture, the transformants underwent a second recombination, removing the vector sequence from the genome through gene exchange. The culture was then serially diluted (10⁻⁶ m² / L). -2 Continuous dilution to 10 -4 The diluted solution was spread onto ordinary solid brain heart extract medium containing 10% sucrose and incubated at 33°C for 48 hours. The strains growing on the sucrose medium did not carry the inserted vector sequence in their genome. The target fragment was amplified by PCR and analyzed by nucleotide sequencing, resulting in the target mutant strain named SMCT136. In this strain, the lysC gene was mutated, with the corresponding start codon changing from GTG to ATG, and the encoded amino acid position 311 changing from threonine to isoleucine. Furthermore, the promoter of the lysC gene was replaced with the strong promoter Psod.

[0114] 2. Construction of strains for enhancing homoserine dehydrogenase expression

[0115] The strain construction method is as described in 1, using SMCT136 as the starting strain, and pK18mobsacB-PcspB-hom G378E The strain was introduced into the starting strain and modified to enhance the expression of homoserine dehydrogenase. The resulting modified strain was named SMCT137. In this strain, the hom gene was mutated, with the corresponding amino acid mutation site being G378E, and the promoter of the hom gene was replaced with the strong promoter PcspB.

[0116] Construction of strains replacing the 3-hydroxy-tetrahydropyridine dicarboxylic acid synthase promoter

[0117] The strain construction method is as described in 1. Using SMCT137 as the starting strain, pK18mobsacB-ΔPdapA::mPdapA was introduced into the starting strain to modify the promoter of the 4-hydroxy-tetrahydropyridine dicarboxylic acid synthase gene by replacing it. The resulting modified strain was named SMCT138. In this strain, the promoter of the 4-hydroxy-tetrahydropyridine dicarboxylic acid synthase gene was replaced with the mutant dapA gene promoter (mPdapA).

[0118] 4. Construction of strains replacing the diaminopimelic acid dehydrogenase promoter

[0119] The strain construction method is as described in 1. Using SMCT137 as the starting strain, pK18mobsacB-ΔPddh::mPdapA was introduced into the starting strain to perform the modification of the diaminopimelic acid dehydrogenase promoter replacement. The resulting modified strain was named SMCT139. In this strain, the promoter of the diaminopimelic acid dehydrogenase gene was replaced with the mutated dapA gene promoter (mPdapA).

[0120] Meanwhile, using SMCT138 as the starting strain, pK18mobsacB-ΔPddh::mPdapA was introduced into the starting strain to perform a modification that replaced the diaminopimelic acid dehydrogenase promoter. The resulting modified strain was named SMCT143.

[0121] 5. Construction of strains replacing the threonine dehydratase (ilvA) promoter

[0122] The strain construction method is as described in 1. Using SMCT137 as the starting strain, pK18mobsacB-ΔPilvA::mPdapA was introduced into the starting strain to perform threonine dehydratase (ilvA) promoter replacement modification. The resulting modified strain was named SMCT140. In this strain, the threonine dehydratase gene ilvA promoter was replaced with the mutated dapA gene promoter (mPdapA).

[0123] Meanwhile, using SMCT143 as the starting strain, pK18mobsacB-ΔPilvA::mPdapA was introduced into the starting strain to perform threonine dehydratase (ilvA) promoter replacement modification, and the resulting modified strain was named SMCT144.

[0124] 6. Construction of strains replacing the threonine dehydratase (tdcB) promoter

[0125] The strain construction method is as described in 1. Using SMCT137 as the starting strain, pK18mobsacB-ΔPtdcB::mPdapA was introduced into the starting strain to perform threonine dehydratase (tdcB) promoter replacement modification. The resulting modified strain was named SMCT141. In this strain, the promoter of the threonine dehydratase gene tdcB was replaced with the mutated dapA gene promoter (mPdapA).

[0126] Meanwhile, using SMCT144 as the starting strain, pK18mobsacB-ΔPtdcB::mPdapA was introduced into the starting strain to perform threonine dehydratase (tdcB) promoter replacement modification, and the resulting modified strain was named SMCT145.

[0127] 7. Construction of strains replacing the citrate synthase promoter

[0128] The strain construction method is as described in 1. Using SMCT137 as the starting strain, pK18mobsacB-ΔPgltA::mPdapA was introduced into the starting strain to perform citrate synthase promoter replacement. The resulting modified strain was named SMCT142. In this strain, the promoter of the citrate synthase gene was replaced with the mutated dapA gene promoter (mPdapA).

[0129] Meanwhile, using SMCT145 as the starting strain, pK18mobsacB-ΔPgltA::mPdapA was introduced into the starting strain to perform citrate synthase promoter replacement modification, and the resulting modified strain was named SMCT146.

[0130] The strains constructed above and their genotype information are shown in Table 2.

[0131] Table 2. Strains and their genotypes

[0132]

[0133] Example 3: Shake-flask fermentation experiment of the constructed strain

[0134] The engineered bacteria constructed in Example 2 were fermented for verification, and the specific method is as follows:

[0135] 1. Culture medium

[0136] Seed activation medium: BHI 3.7%, agar 2%, pH 7.0.

[0137] Seed culture medium: peptone 5 g / L, yeast extract 5 g / L, sodium chloride 10 g / L, ammonium sulfate 16 g / L, urea 8 g / L, potassium dihydrogen phosphate 10.4 g / L, dipotassium hydrogen phosphate 21.4 g / L, biotin 5 mg / L, magnesium sulfate 3 g / L, glucose 50 g / L, pH 7.2.

[0138] Fermentation medium: corn steep liquor 50 mL / L, glucose 30 g / L, ammonium sulfate 4 g / L, MOPS 30 g / L, potassium dihydrogen phosphate 10 g / L, urea 20 g / L, biotin 10 mg / L, magnesium sulfate 6 g / L, ferrous sulfate 1 g / L, vitamin B1·HCl 40 mg / L, calcium pantothenate 50 mg / L, nicotinamide 40 mg / L, manganese sulfate 1 g / L, zinc sulfate 20 mg / L, copper sulfate 20 mg / L, pH 7.2.

[0139] 2. Production of L-threonine by shake-flask fermentation with engineered bacteria

[0140] (1) Seed culture: 1 slant seed of strains SMCT136, SMCT137, SMCT138, SMCT139, SMCT140, SMCT141, SMCT142, SMCT143, SMCT144, SMCT145, and SMCT146 was looped into a 500 mL Erlenmeyer flask containing 20 mL of seed culture medium and cultured at 30 °C and 220 r / min for 16 h with shaking.

[0141] (2) Fermentation culture: 2 mL of seed culture was inoculated into a 500 mL Erlenmeyer flask containing 20 mL of fermentation culture medium and cultured at 33 °C and 220 r / min for 24 h.

[0142] (3) Centrifuge 1 mL of fermentation broth (12000 rpm, 2 min), collect the supernatant, and use HPLC to detect the contents of L-threonine, lysine and isoleucine in the fermentation broth of engineered bacteria and control bacteria.

[0143] The fermentation results of strains that initially demonstrated threonine synthesis capabilities are shown in Table 3.

[0144] Table 3 Threonine production of the starting strains

[0145] strain number OD562 L-Threonine (g / L) Lysine (g / L) Isoleucine (g / L) SMCT136 24 1.2 1.3 0.8 SMCT137 23 2.4 1.1 1.1

[0146] As shown in Table 3, after modifying the wild-type strain ATCC13032 with aspartate kinase, the strain was able to initially accumulate threonine. With the enhancement of homoserine dehydrogenase expression, the threonine production was further increased, and 2.4 g / L of threonine could be accumulated.

[0147] The threonine synthesis of the individually weakened strains dapA, ddh, ilvA, tdcB, and gltA is shown in Table 4.

[0148] Table 4 Threonine production of individual attenuated strains

[0149] strain number OD562 L-Threonine (g / L) Lysine (g / L) Isoleucine (g / L) SMCT137 23 2.4 1.1 1.1 SMCT138 23 3.0 0.8 1.2 SMCT139 23 2.8 0.9 1.1 SMCT140 22 3.2 1.1 0.5 SMCT141 23 3.0 1.1 0.9 SMCT142 22 3.2 1.1 1.1

[0150] The results above indicate that strains SMCT138, SMCT139, SMCT140, SMCT141, and SMCT142 all showed increased threonine production compared to their originating strain SMCT137. Replacing the promoters of dapA and ddh, which are related to lysine synthesis, with mPdapA reduced lysine production by 0.3 and 0.2 g / L, respectively. Replacing the promoters of ilvA and tdcB, which are related to isoleucine synthesis, with mPdapA reduced isoleucine production by 0.6 and 0.2 g / L, respectively. Replacing the gltA promoter with mPdapA increased threonine production by 0.8 g / L.

[0151] The fermentation results of strains SMCT138, SMCT143, SMC144, SMCT145 and SMCT146, which have the five genes dapA, ddh, ilvA, tdcB and gltA superimposed and weakened, are shown in Table 5.

[0152] Table 5 Threonine production of superimposed weakened strains

[0153] strain number OD562 L-Threonine (g / L) Lysine (g / L) Isoleucine (g / L) SMCT137 23 2.4 1.1 1.1 SMCT138 23 3.0 0.8 1.2 SMCT143 22 3.6 0.4 1.3 SMCT144 22 5.0 0.4 0.6 SMCT145 22 6.4 0.4 0.3 SMCT146 21 9.1 0.4 0.3

[0154] The results above indicate that after gradual optimization of the carbon metabolic flux, the threonine yield increased from 2.4 g / L to 9.1 g / L, an increase of 279%. This demonstrates that after the threonine terminal synthesis pathway is opened, optimizing the carbon metabolic flux can significantly improve the strain's ability to produce threonine.

[0155] Although the present invention has been described in detail above with general descriptions and specific embodiments, modifications or improvements can be made to it, which will be obvious to those skilled in the art. Therefore, all such modifications or improvements made without departing from the spirit of the present invention fall within the scope of protection claimed by the present invention. sequence list <110> Langfang Meihua Biotechnology Development Co., Ltd. <120> Promoters, threonine-producing recombinant microorganisms and their applications <130> KHP211124137.2 <160> 39 <170> SIPOSequenceListing 1.0 <210> 1 <211> 222 <212> DNA <213> Artificial Sequence <400> 1 tcacacccaa gagctaaaaa ttcatatagt taagacaaca ttttggctgt aaaagacagc 60 cgtaaaaacc tcttgctcgt gtcaattgtt cttatcggaa tgtggcttgg gcgattgtta 120 tgcaaaagtt gttaggtttt ttgcggggtt gtttaacccc caaatgaggg aagaaggtag 180 aattgaactc tatgagcaca ggtttaacag ctaagaccgg ag 222 <210> 2 <211> 46 <212> DNA <213> Artificial Sequence <400> 2 aattcgagct cggtacccgg ggatccagcg acaggacaag cactgg 46 <210> 3 <211> 40 <212> DNA <213> Artificial Sequence <400> 3 cccggaataa ttggcagcta tgtgcacctt tcgatctacg 40 <210> 4 <211> 40 <212> DNA <213> Artificial Sequence <400> 4 cgtagatcga aaggtgcaca tagctgccaa ttattccggg 40 <210> 5 <211> 41 <212> DNA <213> Artificial Sequence <400> 5 tttctgtacg accagggcca tgggtaaaaa atcctttcgt a 41 <210> 6 <211> 41 <212> DNA <213> Artificial Sequence <400> 6 tacgaaagga ttttttaccc atggccctgg tcgtacagaa a 41 <210> 7 <211> 42 <212> DNA <213> Artificial Sequence <400> 7 tcggaacgag ggcaggtgaa ggtgatgtcg gtggtgccgt ct 42 <210> 8 <211> 42 <212> DNA <213> Artificial Sequence <400> 8 agacggcacc accgacatca ccttcacctg ccctcgttcc ga 42 <210> 9 <211> 46 <212> DNA <213> Artificial Sequence <400> 9 gtaaaacgac ggccagtgcc aagcttagcc tggtaagagg aaacgt 46 <210> 10 <211> 46 <212> DNA <213> Artificial Sequence <400> 10 aattcgagct cggtacccgg ggatccctgc gggcagatcc ttttga 46 <210> 11 <211> 40 <212> DNA <213> Artificial Sequence <400> 11 atttctttat aaacgcaggt catatctacc aaaactacgc 40 <210> 12 <211> 40 <212> DNA <213> Artificial Sequence <400> 12 gcgtagtttt ggtagatatg acctgcgttt ataaagaaat 40 <210> 13 <211> 40 <212> DNA <213> Artificial Sequence <400> 13 gtatatctcc ttctgcagga ataggtatcg aaagacgaaa 40 <210> 14 <211> 40 <212> DNA <213> Artificial Sequence <400> 14 tttcgtcttt cgatacctat tcctgcagaa ggagatatac 40 <210> 15 <211> 41 <212> DNA <213> Artificial Sequence <400> 15 tagccaattc agccaaaacc cccacgcgat cttccacatc c 41 <210> 16 <211> 41 <212> DNA <213> Artificial Sequence <400> 16 ggatgtggaa gatcgcgtgg gggttttggc tgaattggct a 41 <210> 17 <211> 46 <212> DNA <213> Artificial Sequence <400> 17 gtaaaacgac ggccagtgcc aagcttgctg gctcttgccg tcgata 46 <210> 18 <211> 56 <212> DNA <213> Artificial Sequence <400> 18 catgattacg aattcgagct cggtacccgg ggatcctccg cgacccatga attggt 56 <210> 19 <211> 50 <212> DNA <213> Artificial Sequence <400> 19 actatatgaa tttttagctc ttgggtgtga gctttgcgtt aaaagtccat 50 <210> 20 <211> 51 <212> DNA <213> Artificial Sequence <400> 20 tgagcacagg tttaacagct aagaccggag tagagcactt cggcaccgtt g 51 <210> twenty one <211> 56 <212> DNA <213> Artificial Sequence <400> twenty one tcacgacgtt gtaaaacgac ggccagtgcc aagcttaccc ttggcgtcct tgaccg 56 <210> twenty two <211> 56 <212> DNA <213> Artificial Sequence <400> twenty two catgattacg aattcgagct cggtacccgg ggatccgtat cggcagttcc agccat 56 <210> twenty three <211> 50 <212> DNA <213> Artificial Sequence <400> twenty three actatatgaa tttttagctc ttgggtgtga atgatgattc agggacatct 50 <210> twenty four <211> 51 <212> DNA <213> Artificial Sequence <400> twenty four tgagcacagg tttaacagct aagaccggag gattacaaga acatgaccaa c 51 <210> 25 <211> 56 <212> DNA <213> Artificial Sequence <400> 25 tcacgacgtt gtaaaacgac ggccagtgcc aagctttgaa cgccagggat gcgtcg 56 <210> 26 <211> 56 <212> DNA <213> Artificial Sequence <400> 26 catgattacg aattcgagct cggtacccgg ggatccacgt tgatgccaaa ctgggt 56 <210> 27 <211> 50 <212> DNA <213> Artificial Sequence <400> 27 actatatgaa tttttagctc ttgggtgtga ttgtctttgc gtcgaagtac 50 <210> 28 <211> 50 <212> DNA <213> Artificial Sequence <400> 28 tgagcacagg tttaacagct aagaccggag cactagtcaa ccatgagtga 50 <210> 29 <211> 56 <212> DNA <213> Artificial Sequence <400> 29 tcacgacgtt gtaaaacgac ggccagtgcc aagcttgttg cgccggtgcg ctctgc 56 <210> 30 <211> 56 <212> DNA <213> Artificial Sequence <400> 30 catgattacg aattcgagct cggtacccgg ggatcccttc catcttctag tggttc 56 <210> 31 <211> 49 <212> DNA <213> Artificial Sequence <400> 31 actatatgaa tttttagctc ttgggtgtga atgcctgcaa ttgaacttc 49 <210> 32 <211> 50 <212> DNA <213> Artificial Sequence <400> 32 tgagcacagg tttaacagct aagaccggag gaaaacacag gcatgctcac 50 <210> 33 <211> 56 <212> DNA <213> Artificial Sequence <400> 33 tcacgacgtt gtaaaacgac ggccagtgcc aagcttacaa tttctagccc aatgac 56 <210> 34 <211> 55 <212> DNA <213> Artificial Sequence <400> 34 catgattacg aattcgagct cggtacccgg ggatcctttg cgaacttgga ggaga 55 <210> 35 <211> 50 <212> DNA <213> Artificial Sequence <400> 35 actatatgaa tttttagctc ttgggtgtga gcgttttcaa tagttcggtg 50 <210> 36 <211> 51 <212> DNA <213> Artificial Sequence <400> 36 tgagcacagg tttaacagct aagaccggag ccgaacaaat atgtttgaaa g 51 <210> 37 <211> 56 <212> DNA <213> Artificial Sequence <400> 37 tcacgacgtt gtaaaacgac ggccagtgcc aagcttcctc atcgagtggg ttcagc 56 <210> 38 <211> 30 <212> DNA <213> Artificial Sequence <400> 38 tcacacccaa gagctaaaaa ttcatatagt 30 <210> 39 <211> 30 <212> DNA <213> Artificial Sequence <400> 39 ctccggtctt agctgttaaa cctgtgctca 30

Claims

1. A recombinant microorganism, characterized in that, In the recombinant microorganism, the encoding gene of at least one enzyme selected from (1) to (4) is transcribed by a promoter with a nucleotide sequence as shown in SEQ ID NO.1: (1) 4-Hydroxy-tetrahydropyridinedicarboxylic acid synthase; (2) Diaminopimelic acid dehydrogenase; (3) Threonine dehydratase; (4) Citrate synthase; The microorganism in question is Corynebacterium glutamicum.

2. The recombinant microorganism according to claim 1, characterized in that, In the recombinant microorganism, the enzyme activities of aspartate kinase and / or homoserine dehydrogenase are enhanced and / or feedback inhibition is relieved.

3. The recombinant microorganism according to claim 2, characterized in that, The enhancement of enzyme activity is achieved by selecting from the following 1) to 6), or an optional combination thereof: 1) Enhancement is achieved by introducing a plasmid containing the gene encoding the enzyme; 2) Enhanced by increasing the copy number of the gene encoding the enzyme on the chromosome; 3) Enhancement is achieved by altering the promoter sequence of the gene encoding the enzyme on the chromosome; 4) Enhancement is achieved by operatively linking a strong promoter to the gene encoding the enzyme; 5) Enhancement is achieved by altering the amino acid sequence of the enzyme; 6) Enhancement is achieved by altering the nucleotide sequence encoding the enzyme.

4. The method for constructing recombinant microorganisms according to any one of claims 1 to 3, characterized in that, The method includes replacing the promoter of the encoding gene of at least one of 4-hydroxy-tetrahydropyridine dicarboxylic acid synthase, diaminopimelic acid dehydrogenase, threonine dehydratase, and citrate synthase with a promoter whose nucleotide sequence is shown in SEQ ID NO.

1.

5. The method according to claim 4, characterized in that, The method further includes: enhancing the enzyme activity of aspartate kinase and / or homoserine dehydrogenase and / or relieving their feedback inhibition; The enhancement of enzyme activity is achieved by selecting from the following 1) to 6), or an optional combination thereof: 1) Enhancement is achieved by introducing a plasmid containing the gene encoding the enzyme; 2) Enhanced by increasing the copy number of the gene encoding the enzyme on the chromosome; 3) Enhancement is achieved by altering the promoter sequence of the gene encoding the enzyme on the chromosome; 4) Enhancement is achieved by operatively linking a strong promoter to the gene encoding the enzyme; 5) Enhancement is achieved by altering the amino acid sequence of the enzyme; 6) Enhancement is achieved by altering the nucleotide sequence encoding the enzyme.

6. Any of the following applications of the recombinant microorganisms according to any one of claims 1 to 3: (1) Application in the fermentation production of threonine; (2) Application in the selection and breeding of threonine-producing strains; (3) Application in increasing the yield and / or conversion rate of threonine.

7. A method for producing threonine by fermentation, characterized in that, The method includes the step of culturing the recombinant microorganisms according to any one of claims 1 to 3 and isolating threonine from the culture.

Citation Information

Patent Citations

  • Recombinant microorganism for producing l-threonine and method for producing l-threonine by using same

    CN108473992A

  • Provision of malonyl-coa in coryneform bacteria and method for producing polyphenoles and polyketides with coryneform bacteria

    CN112969782A

  • Recombinant corynebacterium glutamicum and method for producing L-threonine

    CN113322218A